WO2013104918A3 - Binding molecule - Google Patents

Binding molecule Download PDF

Info

Publication number
WO2013104918A3
WO2013104918A3 PCT/GB2013/050054 GB2013050054W WO2013104918A3 WO 2013104918 A3 WO2013104918 A3 WO 2013104918A3 GB 2013050054 W GB2013050054 W GB 2013050054W WO 2013104918 A3 WO2013104918 A3 WO 2013104918A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding
binding molecule
antigen
domains
inpgsggt
Prior art date
Application number
PCT/GB2013/050054
Other languages
French (fr)
Other versions
WO2013104918A2 (en
Inventor
Dorian Haskard
Shang-Hung CHANG
Michael Johns
Original Assignee
Imperial Innovations Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Innovations Limited filed Critical Imperial Innovations Limited
Publication of WO2013104918A2 publication Critical patent/WO2013104918A2/en
Publication of WO2013104918A3 publication Critical patent/WO2013104918A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Abstract

The present invention relates to an isolated specific binding member, such as an antibody or fragment thereof, which is capable of binding an antigen on oxidised low density lipoprotein (ox LDL). The antigen is capable of being bound by a member comprising one or more binding domains selected from domains comprising an amino acid sequence substantially as set out as GYAFTNYL, INPGSGGT and ARSFKWKFDY.
PCT/GB2013/050054 2012-01-13 2013-01-11 Binding molecule WO2013104918A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1200563.3 2012-01-13
GB201200563A GB201200563D0 (en) 2012-01-13 2012-01-13 Binding molecule

Publications (2)

Publication Number Publication Date
WO2013104918A2 WO2013104918A2 (en) 2013-07-18
WO2013104918A3 true WO2013104918A3 (en) 2013-08-29

Family

ID=45813980

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2013/050054 WO2013104918A2 (en) 2012-01-13 2013-01-11 Binding molecule

Country Status (2)

Country Link
GB (1) GB201200563D0 (en)
WO (1) WO2013104918A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7262440B2 (en) 2017-08-02 2023-04-21 フェインズ セラピューティクス，インコーポレーテッド Anti-CD47 antibody and uses thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002103363A2 (en) * 2001-06-18 2002-12-27 Medical Research Council Selection by avidity capture
WO2005049635A2 (en) * 2003-11-14 2005-06-02 Vollmers Philip Human monoclonal antibody having fat-reducing effect
CN1730492A (en) * 2004-08-04 2006-02-08 中山大学中山眼科中心 Single-chain antibody for lactoferrin , method for making same and uses
EP1852508A2 (en) * 2001-05-30 2007-11-07 The Kitasato Institute Actinomycetes polynucleotides
US20100311954A1 (en) * 2002-03-01 2010-12-09 Xencor, Inc. Optimized Proteins that Target Ep-CAM
WO2011006915A2 (en) * 2009-07-16 2011-01-20 Glaxo Group Limited Improved anti-serum albumin binding single variable domains
WO2011042548A1 (en) * 2009-10-09 2011-04-14 Sanofi-Aventis Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1852508A2 (en) * 2001-05-30 2007-11-07 The Kitasato Institute Actinomycetes polynucleotides
WO2002103363A2 (en) * 2001-06-18 2002-12-27 Medical Research Council Selection by avidity capture
US20100311954A1 (en) * 2002-03-01 2010-12-09 Xencor, Inc. Optimized Proteins that Target Ep-CAM
WO2005049635A2 (en) * 2003-11-14 2005-06-02 Vollmers Philip Human monoclonal antibody having fat-reducing effect
CN1730492A (en) * 2004-08-04 2006-02-08 中山大学中山眼科中心 Single-chain antibody for lactoferrin , method for making same and uses
WO2011006915A2 (en) * 2009-07-16 2011-01-20 Glaxo Group Limited Improved anti-serum albumin binding single variable domains
WO2011042548A1 (en) * 2009-10-09 2011-04-14 Sanofi-Aventis Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHANG-HUNG CHANG ET AL: "Model IgG Monoclonal Autoantibody-Anti-Idiotype Pair for Dissecting the Humoral Immune Response to Oxidized Low Density Lipoprotein", HYBRIDOMA, vol. 31, no. 2, 17 April 2012 (2012-04-17), pages 87 - 98, XP055067564, ISSN: 1554-0014, DOI: 10.1089/hyb.2011.0058 *

Also Published As

Publication number Publication date
WO2013104918A2 (en) 2013-07-18
GB201200563D0 (en) 2012-02-29

Similar Documents

Publication Publication Date Title
CY1122278T1 (en) ANTI IL-36R ANTIBODIES
WO2014059442A3 (en) Antibody based reagents that specifically recognize toxic oligomeric forms of tau
SG195073A1 (en) Deimmunized serum-binding domains and their use for extending serum half-life
BR112013020500A8 (en) isolated, recombinant or purified antibody
DK2681244T3 (en) CEA ANTIBODIES
CY1122978T1 (en) ANTI-VLA-4 ANTIBODIES
WO2014089335A3 (en) Bcma antigen binding proteins
WO2013138793A3 (en) Affinity reagants for protein purification
BR112013005699A2 (en) 4-1bb binding molecules
BR112018003326A2 (en) thymic stromal lymphopoietin (tslp) binding antibodies and methods of use of antibodies
WO2011133886A3 (en) Production of heteromultimeric proteins
SG179196A1 (en) Coiled coil and/or tether containing protein complexes and uses thereof
UA114707C2 (en) SPECIFIC BINDING MOLECULES WHICH Bind to VEGF I Ang2
MX355255B (en) Fc VARIANTS AND METHODS FOR THEIR PRODUCTION.
RU2018132044A (en) ANTIBODIES AGAINST TAU
WO2013033268A3 (en) Bivalent bromodomain ligands, and methods of using same
EP3786183A3 (en) Antigen binding constructs to cd3
WO2013043933A3 (en) Cd27l antigen binding proteins
WO2008048519A3 (en) Antibodies that bind cxcr7 epitopes
JP2014518898A5 (en)
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
WO2014043509A3 (en) Single domain antibody with c-terminal modification
WO2015006337A3 (en) Compositions and methods for increasing protein half-life in a serum
WO2018194496A3 (en) Monoclonal antibody to pd-l1
MX2017004117A (en) Binding molecules, especially antibodies, binding to l1cam (cd171).

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13700944

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13700944

Country of ref document: EP

Kind code of ref document: A2